The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
O'Leary, D. H., Polak, J. F., Kronmal, R. A., Manolio, T. A., Burke, G. L., & Wolfson, S. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901073400103 · Cited by 4,685
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Chalasani, N., Younossi, Z., Lavine, J. E., Diehl, A. M., Brunt, E. M., Cusi, K., Charlton, M., & Sanyal, A. J. (2012) · Hepatology · doi:10.1002/hep.25762 · Cited by 3,803
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Endothelial Function and Dysfunction: Testing and Clinical Relevance
Deanfield, J. E., Halcox, J. P., & Rabelink, T. J. (2007) · Circulation · doi:10.1161/circulationaha.106.652859 · Cited by 2,710
Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
Tilg, H., & Moschen, A. R. (2010) · Hepatology · doi:10.1002/hep.24001 · Cited by 2,548
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Miller, N. H., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437740.48606.d1 · Cited by 2,261
Neuschwander-Tetri, B. A., Loomba, R., Sanyal, A. J., Lavine, J. E., Van Natta, M. L., Abdelmalek, M. F., Chalasani, N., Dasarathy, S., Diehl, A. M., Hameed, B., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61933-4 · Cited by 2,237
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Singh, S., Allen, A. M., Wang, Z., Prokop, L. J., Murad, M. H., & Loomba, R. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.04.014 · Cited by 1,748
Zhu, L., Baker, S. S., Gill, C., Liu, W., Alkhouri, R., Baker, R. D., & Gill, S. R. (2013) · Hepatology · doi:10.1002/hep.26093 · Cited by 1,708 · cited 1×
“Intestinal dysbiosis is related to the aetiology of NAFLD and progression to NASH [139–141].”
BackgroundOxidative Stress and Vascular Disease
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000150649.39934.13 · Cited by 1,618 · cited 3×
“Increased oxidative stress [71,72] Oxidative stress, plays a central role in pathophysiology of CVD [73]”
BackgroundVisceral fat adipokine secretion is associated with systemic inflammation in obese humans
Fontana, L., Eagon, J. C., Trujillo, M. E., Scherer, P. E., & Klein, S. (2007) · Diabetes · doi:10.2337/db06-1656 · Cited by 1,417 · cited 1×
“Nonetheless, since the liver isn’t directly involved in their production and since systemic levels are rather similar or lower than portal levels [136–138], the role of adipokines in the link between NAFLD and CVD seems minor.”
BackgroundPrognostic Value of Coronary Vascular Endothelial Dysfunction
Halcox, J. P. J., Schenke, W. H., Zalos, G., Mincemoyer, R., Prasad, A., Waclawiw, M. A., Nour, K. R. A., & Quyyumi, A. A. (2002) · Circulation · doi:10.1161/01.cir.0000025404.78001.d8 · Cited by 1,385 · cited 2×
“As well as NASH histology is an accepted surrogate endpoint for clinical benefit in terms of liver disease, measurement of the impact on markers of subclinical CVD (such as cIMT, fibromuscular dysplasia) are accepted surrogate endpoints for clinical benefit in terms of CVD [190].”
BackgroundThe Liver as an Immunological Organ
Racanelli, V., & Rehermann, B. (2006) · Hepatology · doi:10.1002/hep.21060 · Cited by 1,377
The Coagulopathy of Chronic Liver Disease
Tripodi, A., & Mannucci, P. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011170 · Cited by 1,342
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
EUROPEAN GUIDELINES ON CARDIOVASCULAR DISEASE PREVENTION IN CLINICAL PRACTICE
Backer, G. D., Ambrosioni, E., Borch-Johnsen, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., et al. (2005) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2005-1-3-57-65 · Cited by 1,267
Kozlitina, J., Smagris, E., Stender, S., Nordestgaard, B. G., Zhou, H. H., Tybjærg-Hansen, A., Vogt, T. F., Hobbs, H. H., & Cohen, J. C. (2014) · Nature Genetics · doi:10.1038/ng.2901 · Cited by 1,234
Charlton, M. R., Burns, J. M., Pedersen, R. A., Watt, K. D., Heimbach, J. K., & Dierkhising, R. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,106
Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension
Kaess, B. M., Rong, J., Larson, M. G., Hamburg, N. M., Vita, J. A., Levy, D., Benjamin, E. J., Vasan, R. S., & Mitchell, G. F. (2012) · JAMA · doi:10.1001/2012.jama.10503 · Cited by 1,086
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
Sarcopenic obesity: definition, cause and consequences
Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328312c37d · Cited by 1,070
McPherson, S., Hardy, T., Henderson, E., Burt, A. D., Day, C. P., & Anstee, Q. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.034 · Cited by 1,060
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Dumas, M.-E., Barton, R. H., Toye, A., Cloarec, O., Blancher, C., Rothwell, A., Fearnside, J., Tatoud, R., Blanc, V., Lindon, J. C., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601056103 · Cited by 1,042 · cited 1×
“The intestinal microbiome activitymay contribute to both steatosis, due to prompt a relative choline-deficiency, and to increased levels of produced TMA out of this choline [147].”
BackgroundRatziu, V., Harrison, S. A., Francque, S., Bedossa, P., Lehert, P., Serfaty, L., Romero-Gomez, M., Boursier, J., Abdelmalek, M., Caldwell, S., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.01.038 · Cited by 1,035
Self-citationRole of homocysteine in the development of cardiovascular disease
Ganguly, P., & Alam, S. F. (2015) · Nutrition Journal · doi:10.1186/1475-2891-14-6 · Cited by 1,028
Speliotes, E. K., Yerges-Armstrong, L. M., Wu, J., Hernaez, R., Kim, L. J., Palmer, C. D., Gudnason, V., Eiriksdottir, G., Garcia, M. E., Launer, L. J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001324 · Cited by 984
Fatty Liver: A Novel Component of the Metabolic Syndrome
Kotronen, A., & Yki-Järvinen, H. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.147538 · Cited by 797
Decreased Survival of Subjects With Elevated Liver Function Tests During A 28-Year Follow-Up
Söderberg, C., Stål, P., Askling, J., Glaumann, H., Lindberg, G., Marmur, J., & Hultcrantz, R. (2010) · Hepatology · doi:10.1002/hep.23314 · Cited by 754
Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
Lonardo, A., Ballestri, S., Marchesini, G., Angulo, P., & Loria, P. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.020 · Cited by 685
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Liu, Y.-L., Reeves, H. L., Burt, A. D., Tiniakos, D., McPherson, S., Leathart, J. B. S., Allison, M. E. D., Alexander, G. J., Piguet, A.-C., Anty, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms5309 · Cited by 623
Self-citationIncreased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease
Dushay, J., Chui, P. C., Gopalakrishnan, G. S., Varela–Rey, M., Crawley, M., Fisher, F. M., Badman, M. K., Martinez–Chantar, M. L., & Maratos–Flier, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.054 · Cited by 607
Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
Wieckowska, A., Papouchado, B. G., Li, Z., Lopez, R., Zein, N. N., & Feldstein, A. E. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01774.x · Cited by 597
Spencer, M. D., Hamp, T. J., Reid, R. W., Fischer, L. M., Zeisel, S. H., & Fodor, A. A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.049 · Cited by 593
Sarcopenic obesity: a critical appraisal of the current evidence
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M., & Siervo, M. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.06.010 · Cited by 589 · cited 2×
“The pathophysiology is rather complex with involvement of joint risk factors/mechanisms [165,168].”
BackgroundPirola, C. J., Fernández Gianotti, T., Castaño, G. O., Mallardi, P., San Martino, J., Mora Gonzalez Lopez Ledesma, M., Flichman, D., Mirshahi, F., Sanyal, A. J., & Sookoian, S. (2015) · Gut · doi:10.1136/gutjnl-2014-306996 · Cited by 564
Rijzewijk, L. J., van der Meer, R. W., Smit, J. W. A., Diamant, M., Bax, J. J., Hammer, S., Romijn, J. A., de Roos, A., & Lamb, H. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.062 · Cited by 559 · cited 1×
“LV remodelling and mass ↑ [31,32, 200-202] Myocardial steatosis in NAFLD [203,204] leads to diastolic dysfunction [203] (although no diastolic dysfunction in [204,205]); Reduced myocardial metabolism [206] (although conserved in [200,201]); Increased cardiac output and LV overload [32,200] Diastolic dysfunction [32,20…”
BackgroundSystematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S., & Caldwell, S. H. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.019 · Cited by 552
Liu, Y.-L., Patman, G. L., Leathart, J. B. S., Piguet, A.-C., Burt, A. D., Dufour, J.-F., Day, C. P., Daly, A. K., Reeves, H. L., & Anstee, Q. M. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.02.030 · Cited by 549
The role of hepatokines in metabolism
Stefan, N., & Häring, H.-U. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.258 · Cited by 500
Animal models of nonalcoholic fatty liver disease
Hebbard, L., & George, J. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.191 · Cited by 499
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Vascular Endothelial Growth Factors
Ylä-Herttuala, S., Rissanen, T. T., Vajanto, I., & Hartikainen, J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.053 · Cited by 480
Endothelial Dysfunction The First Step Toward Coronary Arteriosclerosis
Vanhoutte, P. M. (2009) · Circulation Journal · doi:10.1253/circj.cj-08-1169 · Cited by 467
The role of the gut microbiota in nonalcoholic fatty liver disease
Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457
Role of Angiogenesis in Cardiovascular Disease: A Critical Appraisal
Khurana, R., Simons, M., Martin, J. F., & Zachary, I. C. (2005) · Circulation · doi:10.1161/circulationaha.105.535294 · Cited by 451
The Gut Microbial Endocrine Organ: Bacterially Derived Signals Driving Cardiometabolic Diseases
Brown, J. M., & Hazen, S. L. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-060513-093205 · Cited by 438
Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional Imaging
Neglia, D., Rovai, D., Caselli, C., Pietila, M., Teresinska, A., Aguadé-Bruix, S., Pizzi, M. N., Todiere, G., Gimelli, A., Schroeder, S., et al. (2015) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.114.002179 · Cited by 423
Heilbronn, L., Smith, S. R., & Ravussin, E. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802853 · Cited by 412
Nonalcoholic Fatty Liver Disease: Pathologic Patterns and Biopsy Evaluation in Clinical Research
Kleiner, D., & Brunt, E. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1306421 · Cited by 402
Li, H., Fang, Q., Gao, F., Fan, J., Zhou, J., Wang, X., Zhang, H., Pan, X., Bao, Y., Xiang, K., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.05.018 · Cited by 399
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
Lazo, M., Hernaez, R., Bonekamp, S., Kamel, I. R., Brancati, F. L., Guallar, E., & Clark, J. M. (2011) · BMJ · doi:10.1136/bmj.d6891 · Cited by 395
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
Loomba, R., Schork, N., Chen, C.-H., Bettencourt, R., Bhatt, A., Ang, B., Nguyen, P., Hernandez, C., Richards, L., Salotti, J., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.011 · Cited by 389
Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385
Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease
Satapathy, S., & Sanyal, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562943 · Cited by 371
Sanyal, A. J., Friedman, S. L., McCullough, A. J., & Dimick‐Santos, L. (2015) · Hepatology · doi:10.1002/hep.27678 · Cited by 354
Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation
KOFLER, S., NICKEL, T., & WEIS, M. (2005) · Clinical Science · doi:10.1042/cs20040174 · Cited by 353
Oni, E. T., Agatston, A. S., Blaha, M. J., Fialkow, J., Cury, R., Sposito, A., Erbel, R., Blankstein, R., Feldman, T., Al-Mallah, M. H., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.07.052 · Cited by 352
Stepanova, M., & Younossi, Z. M. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.12.039 · Cited by 352
Chalasani, N., Deeg, M. A., & Crabb, D. W. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30159.x · Cited by 343
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Z., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2013) · Giornale Italiano di Cardiologia · doi:10.1714/1264.13964 · Cited by 343
Wong, V. W.-S., Tse, C.-H., Lam, T. T.-Y., Wong, G. L.-H., Chim, A. M.-L., Chu, W. C.-W., Yeung, D. K.-W., Law, P. T.-W., Kwan, H.-S., Yu, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062885 · Cited by 342
Lee, Y.-H., Jung, K. S., Kim, S. U., Yoon, H.-J., Yun, Y. J., Lee, B.-W., Kang, E. S., Han, K.-H., Lee, H. C., & Cha, B.-S. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.051 · Cited by 340
From NAFLD in clinical practice to answers from guidelines
Nascimbeni, F., Pais, R., Bellentani, S., Day, C. P., Ratziu, V., Loria, P., & Lonardo, A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.05.044 · Cited by 337
Ryan, C. K., Johnson, L. A., Germin, B. I., & Marcos, A. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.36740 · Cited by 326
du Plessis, J., van Pelt, J., Korf, H., Mathieu, C., van der Schueren, B., Lannoo, M., Oyen, T., Topal, B., Fetter, G., Nayler, S., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.044 · Cited by 325
Self-citationThe gut microbiome, diet, and links to cardiometabolic and chronic disorders
Aron-Wisnewsky, J., & Clément, K. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.191 · Cited by 325
Angiopoietin-Like Proteins: A Comprehensive Look
Santulli, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00004 · Cited by 320
Verma, S., Jensen, D., Hart, J., & Mohanty, S. R. (2013) · Liver International · doi:10.1111/liv.12226 · Cited by 314
Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions
Iwakiri, Y., Shah, V., & Rockey, D. C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.047 · Cited by 311
Plasma Fetuin-A Levels and the Risk of Myocardial Infarction and Ischemic Stroke
Weikert, C., Stefan, N., Schulze, M. B., Pischon, T., Berger, K., Joost, H.-G., Häring, H.-U., Boeing, H., & Fritsche, A. (2008) · Circulation · doi:10.1161/circulationaha.108.814418 · Cited by 310
VanWagner, L. B., Wilcox, J. E., Colangelo, L. A., Lloyd‐Jones, D. M., Carr, J. J., Lima, J. A., Lewis, C. E., Rinella, M. E., & Shah, S. J. (2015) · Hepatology · doi:10.1002/hep.27869 · Cited by 305
Holmen, O. L., Zhang, H., Fan, Y., Hovelson, D. H., Schmidt, E. M., Zhou, W., Guo, Y., Zhang, J., Langhammer, A., Løchen, M.-L., et al. (2014) · Nature Genetics · doi:10.1038/ng.2926 · Cited by 302
Yoneda, M., Mawatari, H., Fujita, K., Iida, H., Yonemitsu, K., Kato, S., Takahashi, H., Kirikoshi, H., Inamori, M., Nozaki, Y., et al. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-007-2060-x · Cited by 294
Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
Hennige, A. M., Staiger, H., Wicke, C., Machicao, F., Fritsche, A., Häring, H.-U., & Stefan, N. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001765 · Cited by 282
Hepatic Microcirculation in Fatty Liver Disease
Farrell, G. C., Teoh, N. C., & Mccuskey, R. S. (2008) · The Anatomical Record · doi:10.1002/ar.20715 · Cited by 266
Current efforts and trends in the treatment of NASH
Ratziu, V., Goodman, Z., & Sanyal, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.041 · Cited by 262
Ballestri, S. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1724 · Cited by 262
Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
Pasarín, M., La Mura, V., Gracia-Sancho, J., García-Calderó, H., Rodríguez-Vilarrupla, A., García-Pagán, J. C., Bosch, J., & Abraldes, J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032785 · Cited by 247
Tools in the Assessment of Sarcopenia
Cooper, C., Fielding, R., Visser, M., van Loon, L. J., Rolland, Y., Orwoll, E., Reid, K., Boonen, S., Dere, W., Epstein, S., et al. (2013) · Calcified Tissue International · doi:10.1007/s00223-013-9757-z · Cited by 246
Katagiri, H., Yamada, T., & Oka, Y. (2007) · Circulation Research · doi:10.1161/circresaha.107.151621 · Cited by 235
Li, L., Chen, L., Hu, L., Liu, Y., Sun, H.-Y., Tang, J., Hou, Y.-J., Chang, Y.-X., Tu, Q.-Q., Feng, G.-S., et al. (2011) · Hepatology · doi:10.1002/hep.24552 · Cited by 234
Siddiqui, M. S., Fuchs, M., Idowu, M. O., Luketic, V. A., Boyett, S., Sargeant, C., Stravitz, R. T., Puri, P., Matherly, S., Sterling, R. K., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.10.008 · Cited by 231
Perseghin, G., Lattuada, G., De Cobelli, F., Esposito, A., Belloni, E., Ntali, G., Ragogna, F., Canu, T., Scifo, P., Del Maschio, A., et al. (2008) · Hepatology · doi:10.1002/hep.21983 · Cited by 210
Mohanty, A., Tate, J. P., & Garcia-Tsao, G. (2016) · Gastroenterology · doi:10.1053/j.gastro.2015.10.007 · Cited by 206
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Rodella, S., Zoppini, G., Mantovani, W., Barbieri, E., & Byrne, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057183 · Cited by 197
Inflammatory biomarkers for predicting cardiovascular disease
Stoner, L., Lucero, A. A., Palmer, B. R., Jones, L. M., Young, J. M., & Faulkner, J. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.05.070 · Cited by 194
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
Tripodi, A., Fracanzani, A. L., Primignani, M., Chantarangkul, V., Clerici, M., Mannucci, P. M., Peyvandi, F., Bertelli, C., Valenti, L., & Fargion, S. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.03.013 · Cited by 192
Yang, S. J., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0620 · Cited by 191
Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
Haukeland, J. W., Dahl, T. B., Yndestad, A., Gladhaug, I. P., Løberg, E. M., Haaland, T., Konopski, Z., Wium, C., Aasheim, E. T., Johansen, O. E., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0864 · Cited by 186
Could inflammatory markers help diagnose nonalcoholic steatohepatitis?
Tarantino, G., Conca, P., Pasanisi, F., Ariello, M., Mastrolia, M., Arena, A., Tarantino, M., Scopacasa, F., & Vecchione, R. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3283229b40 · Cited by 185
Verrijken, A., Francque, S., Mertens, I., Prawitt, J., Caron, S., Hubens, G., Van Marck, E., Staels, B., Michielsen, P., & Van Gaal, L. (2014) · Hepatology · doi:10.1002/hep.26510 · Cited by 181
Self-citationPlasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation
Alessi, M.-C., Bastelica, D., Mavri, A., Morange, P., Berthet, B., Grino, M., & Juhan-Vague, I. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000077401.36885.bb · Cited by 178
Oxidant Stress and Antioxidant Status Among Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Madan, K., Bhardwaj, P., Thareja, S., Gupta, S. D., & Saraya, A. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000212608.59090.08 · Cited by 174
The emerging roles of microvesicles in liver diseases
Lemoinne, S., Thabut, D., Housset, C., Moreau, R., Valla, D., Boulanger, C. M., & Rautou, P.-E. (2014) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2014.7 · Cited by 172
Vitamin D And Nonalcoholic Fatty Liver Disease (Nafld): Is It More Than Just An Association?
Kwok, R. M., Torres, D. M., & Harrison, S. A. (2013) · Hepatology · doi:10.1002/hep.26390 · Cited by 169
Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease
Hallsworth, K., Hollingsworth, K. G., Thoma, C., Jakovljević, D. G., MacGowan, G. A., Anstee, Q. M., Taylor, R., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.015 · Cited by 162
Goland, S., Shimoni, S., Zornitzki, T., Knobler, H., Azoulai, O., Lutaty, G., Melzer, E., Orr, A., Caspi, A., & Malnick, S. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225668.53673.e6 · Cited by 162
The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2
Day, C., & Anstee, Q. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562947 · Cited by 161
Procoagulant imbalance in patients with non-alcoholic fatty liver disease
Tripodi, A., Fracanzani, A. L., Chantarangkul, V., Primignani, M., & Fargion, S. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.025 · Cited by 161
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
Coulon, S., Francque, S., Colle, I. O., Verrijken, A., Blomme, B., Heindryckx, F., Munter, S. D., Prawitt, J., Caron, S., Staels, B., et al. (2012) · Cytokine · doi:10.1016/j.cyto.2012.05.001 · Cited by 148
Self-citationPacana, T., Cazanave, S. C., Verdianelli, A., Patel, V. A., Min, H., Mirshahi, F., Quinlivan, E. P., & Sanyal, A. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136822 · Cited by 146
Change of Serum Albumin and Risk of Cardiovascular Disease and All-Cause Mortality
Schalk, B. W. M., Visser, M., Bremmer, M. A., Penninx, B. W. J. H., Bouter, L. M., & Deeg, D. J. H. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj312 · Cited by 145
The Coagulopathy of Chronic Liver Disease
Tripodi, A., & Mannucci, P. M. (2012) · Survey of Anesthesiology · doi:10.1097/01.sa.0000414257.36213.3a · Cited by 143
Musso, G., Gambino, R., Michieli, F. D., Durazzo, M., Pagano, G., & Cassader, M. (2008) · Hepatology · doi:10.1002/hep.22142 · Cited by 137
Francque, S., Laleman, W., Verbeke, L., Steenkiste, C. V., Casteleyn, C. R., Kwanten, W. J., Dyck, C. V., D'Hondt, M., Ramon, A., Vermeulen, W., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.103 · Cited by 136
Self-citationSookoian, S. C., Castaño, G. O., Burgueño, A. L., Rosselli, M. S., Gianotti, T. F., Mallardi, P., Martino, J. S., & Pirola, C. J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.10.011 · Cited by 136
Additive relationship between serum fibroblast growth factor 21 level and coronary artery disease
Shen, Y., Ma, X., Zhou, J., Pan, X., Hao, Y., Zhou, M., Lu, Z., Gao, M., Bao, Y., & Jia, W. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-124 · Cited by 135
Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease
Kotronen, A., Joutsi‐Korhonen, L., Sevastianova, K., Bergholm, R., Hakkarainen, A., Pietiläinen, K. H., Lundbom, N. M. I., Rissanen, A., Lassila, R., & Yki‐Järvinen, H. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02375.x · Cited by 134
Emerging Role of High-Mobility Group Box 1 (HMGB1) in Liver Diseases
Chen, R., Hou, W., Zhang, Q., Kang, R., Fan, X., & Tang, D. (2013) · Molecular Medicine · doi:10.2119/molmed.2013.00099 · Cited by 132
Pastore, A., Alisi, A., Giovamberardino, G. D., Crudele, A., Ceccarelli, S., Panera, N., Dionisi‐Vici, C., & Nobili, V. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151121202 · Cited by 129
Wang, Y., Parlevliet, E. T., Geerling, J. J., van der Tuin, S. J. L., Zhang, H., Bieghs, V, Jawad, A. H. M., Shiri‐Sverdlov, R., Bot, I., de Jager, S. C. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12490 · Cited by 126
The Impact of Postprandial Lipemia in Accelerating Atherothrombosis
Roche, H. M., & Gibney, M. J. (2000) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/204748730000700504 · Cited by 124
The impact of blood coagulability on atherosclerosis and cardiovascular disease
Loeffen, R., Spronk, H. M. H., & Cate, H. T. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04782.x · Cited by 122
Gülşen, M., Yeşilova, Z., Bağcı, S., et al. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03891.x · Cited by 122
Bortoluzzi, A., Ceolotto, G., Gola, E., Sticca, A., Bova, S., Morando, F., Piano, S. S., Fasolato, S., Rosi, S., Gatta, A., et al. (2012) · Hepatology · doi:10.1002/hep.26021 · Cited by 122
Kuś, E., Gregorius, A., & Chłopicki, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.04.010 · Cited by 120
Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21
Domouzoglou, E. M., Naka, K. Κ., Vlahos, A. P., Papafaklis, M. I., Michalis, L. K., Tsatsoulis, A., & Maratos–Flier, E. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00527.2015 · Cited by 118
Fotbolcu, H., Yakar, T., Duman, D., Karaahmet, T., Tigen, K., Çevik, C., Kurtoğlu, Ü., & Dindar, İ. (2010) · PubMed · Cited by 117
Alkhouri, N., Tamimi, T., Yerian, L. M., López, R., Zein, N. N., & Feldstein, A. E. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1075-y · Cited by 117
Zhou, Y., Llauradó, G., Orešič, M., Hyötyläinen, T., Orho‐Melander, M., & Yki‐Järvinen, H. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.010 · Cited by 115
Bernsmeier, C., Meyer‐Gerspach, A. C., Blaser, L. S., Jeker, L., Steinert, R. E., Heim, M. H., & Beglinger, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087488 · Cited by 113
The genetic architecture of NAFLD among inbred strains of mice
Hui, S. T. Y., Parks, B. W., Org, E., Norheim, F., Che, N., Pan, C., Castellani, L. W., Charugundla, S., Dirks, D. L., Psychogios, N., et al. (2015) · eLife · doi:10.7554/elife.05607 · Cited by 113
Choi, H. Y., Hwang, S. Y., Lee, C. H., Hong, H. C., Yang, S. J., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.1.63 · Cited by 111
Genomic aspects of NAFLD pathogenesis
Naik, A., Košir, R., & Rozman, D. (2013) · Genomics · doi:10.1016/j.ygeno.2013.03.007 · Cited by 108
Aspirin use is associated with lower indices of liver fibrosis among adults in the United States
Jiang, Z. G., Feldbrügge, L., Tapper, E. B., Popov, Y. V., Ghaziani, T., Afdhal, N. H., Robson, S. C., & Mukamal, K. J. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13515 · Cited by 107
Sookoian, S. C., Gianotti, T. F., Rosselli, M. S., Burgueño, A. L., Castaño, G. O., & Pirola, C. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.014 · Cited by 105
Coulon, S., Legry, V., Heindryckx, F., Steenkiste, C. V., Casteleyn, C. R., Olievier, K., Libbrecht, L. J., Carmeliet, P., Jonckx, B., Stassen, J., et al. (2013) · Hepatology · doi:10.1002/hep.26219 · Cited by 103
Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes
Targher, G., Valbusa, F., Bonapace, S., Bertolini, L., Zenari, L., Pichiri, I., Mantovani, A., Zoppini, G., Bonora, E., Barbieri, E., et al. (2014) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2014.01.005 · Cited by 101
Heart valve calcification in patients with type 2 diabetes and nonalcoholic fatty liver disease
Mantovani, A., Pernigo, M., Bergamini, C., Bonapace, S., Lipari, P., Valbusa, F., Bertolini, L., Zenari, L., Pichiri, I., Dauriz, M., et al. (2015) · Metabolism · doi:10.1016/j.metabol.2015.04.003 · Cited by 101
Granér, M., Nyman, K., Sirén, R., Pentikäinen, M. O., Lundbom, J., Hakkarainen, A., Lauerma, K., Lundbom, N. M. I., Nieminen, M. S., & Taskinen, M. (2014) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.114.001979 · Cited by 101
Plasmatic higher levels of homocysteine in Non-alcoholic fatty liver disease (NAFLD)
de Carvalho, S. C. R., Muniz, M. T. C., Siqueira, M. D. V., de Siqueira, É. R. F., Gomes, A. V., da Silva, K. A., Bezerra, L. C. L., D’Almeida, V., de Oliveira, C. P. M. S., & Pereira, L. M. M. B. (2013) · Nutrition Journal · doi:10.1186/1475-2891-12-37 · Cited by 100
Francque, S., Verrijken, A., Mertens, I. L., Hubens, G., Marck, E. V., Pelckmans, P. A., Gaal, L. V., & Michielsen, P. P. (2010) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32833f14a1 · Cited by 99
Self-citationChong, L., Hsu, Y., Lee, T., Lin, Y., Chiu, Y.-T., Yang, K., Wu, J., & Huang, Y. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0248-8 · Cited by 99
Serum folate and homocysteine levels in obese females with non-alcoholic fatty liver
Hirsch, S., Poniachick, J., Avendaño, M., Attila Csendes, J., Patricio Burdiles, P., Smok, G., Díaz, J. C., & de la Maza, M. P. (2005) · Nutrition · doi:10.1016/j.nut.2004.03.022 · Cited by 99
Fetuin-A, Type 2 Diabetes, and Risk of Cardiovascular Disease in Older Adults
Jensen, M. K., Bartz, T. M., Mukamal, K. J., Djoussé, L., Kizer, J. R., Tracy, R. P., Zieman, S. J., Rimm, E. B., Siscovick, D. S., Shlipak, M. G., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1591 · Cited by 97
Bravo, E., Palleschi, S., Aspichueta, P., Buqué, X., Rossi, B., Cano, A., Napolitano, M., Ochoa, B., & Botham, K. M. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-60 · Cited by 96
Long, M. T., Wang, N., Larson, M. G., Mitchell, G. F., Palmisano, J. N., Vasan, R. S., Hoffmann, U., Speliotes, E. K., Vita, J. A., Benjamin, E. J., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.305200 · Cited by 94
Cassader, M., Gambino, R., Musso, G., Depetris, N., Mecca, F., Cavallo‐Perin, P., Pacini, G., Rizzetto, M., & Pagano, G. (2001) · Lipids · doi:10.1007/s11745-001-0822-5 · Cited by 93
Doğru, T., Genç, H., Tapan, S., Aslan, F., Erçin, C. N., Örs, F., Kara, M., Sertoğlu, E., Karslıoğlu, Y., Bağcı, S., et al. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04460.x · Cited by 90
Awareness and opinions of non‐alcoholic fatty liver disease by hospital specialists
Bergqvist, C. ‐., Skoien, R., Horsfall, L. U., Clouston, A. D., Jonsson, J. R., & Powell, E. E. (2012) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2012.02848.x · Cited by 89
TM6SF2: Catch-22 in the Fight Against Nonalcoholic Fatty Liver Disease and Cardiovascular Disease?
Kahali, B., Liu, Y., Daly, A. K., Day, C. P., Anstee, Q. M., & Speliotes, E. K. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.01.038 · Cited by 89
Vonghia, L., Magrone, T., Verrijken, A., Michielsen, P. P., Gaal, L. V., Jirillo, E., & Francque, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143380 · Cited by 89
Self-citationInsulin resistance and liver microcirculation in a rat model of early NAFLD
Pasarín, M., Abraldeṣ, J. G., Rodríguez-Vilarrupla, A., Mura, V. L., García‐Pagán, J. C., & Bosch, J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.01.053 · Cited by 87
Primary care practitioners survey of non-alcoholic fatty liver disease
Said, A., Gagovic, V., Malecki, K. M. C., Givens, M. L., & Nieto, F. J. (2013) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31317-1 · Cited by 87
Santilli, F., Davì, G., & Patrono, C. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.06.009 · Cited by 85
Madan, S., John, F., Pyrsopoulos, N., & Pitchumoni, C. S. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000429 · Cited by 84
Serum homocysteine levels, oxidative stress and cardiovascular risk in non-alcoholic steatohepatitis
Leach, N. V., Dronca, E., Vesa, Ș. C., Sâmpelean, D., Crăciun, E. C., Lupșor‐Platon, M., Crișan, D., Tarau, R., Rusu, R., Para, I., et al. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.09.007 · Cited by 83
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
Castéra, L. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562948 · Cited by 83
Cost-utility analysis of nonalcoholic steatohepatitis screening
Zhang, E. W., Wartelle‐Bladou, C., Lepanto, L., Lachaîne, J., Cloutier, G., & Tang, A. (2015) · European Radiology · doi:10.1007/s00330-015-3731-2 · Cited by 82
Bonci, E., Chiesa, C., Versacci, P., Anania, C., Silvestri, L. M., & Pacifico, L. (2015) · BioMed Research International · doi:10.1155/2015/213737 · Cited by 82
Adachi, H., Fujiwara, Y., Kondo, T., Nishikawa, T., Ogawa, R., Matsumura, T., Ishii, N., Nagai, R., Miyata, K., Tabata, M., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.018 · Cited by 80
Sünbül, M., Ağırbaşlı, M. A., Durmuş, E., Kıvrak, T., Akın, H., Aydın, Y., Ergelen, R., & Yilmaz, Y. N. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.10.004 · Cited by 80
The Role of Skeletal Muscle in Development of Nonalcoholic Fatty Liver Disease
Moon, J. S., Yoon, J. S., Won, K. C., & Lee, H. W. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.4.278 · Cited by 77
Systematic review with network meta-analysis: statins and risk of hepatocellular carcinoma
Zhou, Y., Zhu, G., Wang, Y., Zheng, J.-N., Ruan, L.-Y., Cheng, Z., Hu, B., Fu, S., & Zheng, M. (2016) · Oncotarget · doi:10.18632/oncotarget.7832 · Cited by 76
Kalhan, S. C., Edmison, J. M., Marczewski, S., Dasarathy, S., Gruca, L. L., Bennett, C. D., Duenas, C., & López, R. (2011) · Clinical Science · doi:10.1042/cs20110060 · Cited by 75
Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease
Sönmez, A., Nikolić, D., Doğru, T., Erçin, C. N., Genç, H., Cesur, M., Tapan, S., Karslıoğlu, Y., Montalto, G., Banach, M., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.03.010 · Cited by 75
Assessment of Endothelial Dysfunction in Childhood Obesity and Clinical Use
Bruyndonckx, L., Hoymans, V. Y., Craenenbroeck, A. H. V., Vissers, D. K., Vrints, C. J., Ramet, J., & Conraads, V. M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/174782 · Cited by 75
Serum homocysteine levels in patients with nonalcoholic fatty liver disease
Pοlyzos, S. A., Kountouras, J., Patsiaoura, K., Katsiki, E., Zafeiriadou, E., Deretzi, G., Zavos, C., Gavalas, E., Katsinelos, P., Mane, V., et al. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31488-7 · Cited by 74
Distrutti, E., Mencarelli, A., Santucci, L., Renga, B., Orlandi, S., Donini, A., Shah, V. H., & Fiorucci, S. (2007) · Hepatology · doi:10.1002/hep.22037 · Cited by 73
Sato, M., Kamada, Y., Takeda, Y., Kida, S., Ohara, Y., Fujii, H., Akita, M., Mizutani, K., Yoshida, Y., Yamada, M., et al. (2014) · Liver International · doi:10.1111/liv.12478 · Cited by 72
Andrassy, M., Volz, H. C., Schüssler, A., Gitsioudis, G., Hofmann, N., Laohachewin, D., Wienbrandt, A. R., Kaya, Z., Bierhaus, A., Giannitsis, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052081 · Cited by 70
Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis
Gill, R. M., Belt, P. H., Wilson, L., Bass, N. M., & Ferrell, L. D. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182254283 · Cited by 69
Hepatic Steatosis Is Associated With Aortic Valve Sclerosis in the General Population
Markus, M. R. P., Baumeister, S. E., Stritzke, J., Dörr, M., Wallaschofski, H., Völzke, H., & Lieb, W. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.300556 · Cited by 66
The Spontaneous Course of Liver Enzymes and Its Correlation in Nonalcoholic Fatty Liver Disease
Charatcharoenwitthaya, P., Lindor, K. D., & Angulo, P. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2098-3 · Cited by 64
Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease
Luo, J., Xu, L., Li, J., & Zhao, S.-P. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000254 · Cited by 63
Yilmaz, Y. N., Ulukaya, E., Atuğ, Ö., & Dolar, E. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32832b77ae · Cited by 63
Bonapace, S., Valbusa, F., Bertolini, L., Pichiri, I., Mantovani, A., Rossi, A., Zenari, L., Barbieri, E., & Targher, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088371 · Cited by 62
Hatsuda, S., Shoji, T., Shinohara, K., Kimoto, E., Mori, K., Fukumoto, S., Koyama, H., Emoto, M., & Nishizawà, Y. (2006) · Journal of Vascular Research · doi:10.1159/000098153 · Cited by 60
Ouweneel, A. B., & Eck, M. V. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.10.009 · Cited by 60
Wolfs, M. G. M., Gruben, N., Rensen, S. S., Verdam, F. J., Greve, J.-W. M., Driessen, A. L. C., Wijmenga, C., Buurman, W. A., Franke, L., Scheja, L., et al. (2015) · Nutrition and Diabetes · doi:10.1038/nutd.2014.43 · Cited by 57
Weyland, P., Grant, W. B., & Howie‐Esquivel, J. (2014) · Nutrients · doi:10.3390/nu6093403 · Cited by 57
Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients
Kahraman, A., Sowa, J., Schlattjan, M., Sydor, S., Pronadl, M., Wree, A., Beilfuss, A., Kılıçarslan, A., Altınbaş, A., Bechmann, L. P., et al. (2013) · Clinical Science · doi:10.1042/cs20120542 · Cited by 57
Northup, P. G., Argo, C. K., Shah, N. L., et al. (2012) · Seminars in Liver Disease · doi:10.1055/s-0032-1306425 · Cited by 57
Tárnoki, Á. D., Tárnoki, D. L., Bata, P., Littvay, L., Osztovits, J., Jermendy, G., Karlinger, K., Lannert, À., Préda, I., Kiss, R. G., et al. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02823.x · Cited by 56
Association between Inflammatory Markers and Liver Fat: The Multi-Ethnic Study of Atherosclerosis
Hamirani, Y. S., Katz, R., Nasir, K., Zeb, I., Blaha, M. J., Blumenthal, R. S., Kronmal, R., & Budoff, M. J. (2014) · Journal of Clinical & Experimental Cardiology · doi:10.4172/2155-9880.1000344 · Cited by 56
Chiang, C.-H., Huang, P., Chung, F., Chen, Z.-Y., Leu, H., Huang, C., Wu, T.-C., Chen, J., & Lin, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031799 · Cited by 56
Karabay, C. Y., Kocabay, G., Kalaycı, A., Çolak, Y., Oduncu, V., Akgün, T., Kalkan, S., Güler, A., & Kırma, C. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000008 · Cited by 55
Nonalcoholic fatty liver in nondiabetic patients with acute coronary syndromes
Boddi, M., Tarquini, R., Chiostri, M., Marra, F., Valente, S., Giglioli, C., Gensini, G. F., & Abbate, R. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12065 · Cited by 55
Non-alcoholic fatty liver – Perhaps not so benign
Adams, L. A., & Ratziu, V. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.005 · Cited by 53
Cassidy, S., Hallsworth, K., Thoma, C., MacGowan, G. A., Hollingsworth, K. G., Day, C. P., Taylor, R., Jakovljević, D. G., & Trenell, M. I. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0187-2 · Cited by 51
Dahlhoff, C., Desmarchelier, C., Sailer, M., Fürst, R. W., Haag, A., Ulbrich, S. E., Hummel, B., Obeid, R., Geisel, J., Bader, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057387 · Cited by 49
Shirai, Y., Yoshiji, H., Noguchi, R., Kaji, K., Aihara, Y., Douhara, A., Moriya, K., Namisaki, T., Kawaratani, H., & Fukui, H. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12112 · Cited by 47
Gkaliagkousi, Ε., & Δούμα, Σ. (2009) · Europe PMC (PubMed Central) · Cited by 42
Zang, S., Ma, X., Zhuang, Z., Liu, J., Bian, D., Xun, Y., Zhang, Q., Zhao, F., Yang, W., Liu, J., et al. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12499 · Cited by 38
Byeon, C.-H., Kang, K.-Y., Kang, S.-H., & Bae, E. (2015) · PubMed Central · doi:10.11909/j.issn.1671-5411.2015.04.007 · Cited by 35
Expresión génica en pacientes obesos con enfermedad hepática por depósito de grasa
Cayon, A., Crespo, J., Guerra, A. R., & Pons‐Romero, F. (2008) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082008000400004 · Cited by 31
Ballestri, S., Meschiari, E., Baldelli, E., Musumeci, F. E., Romagnoli, D., Trenti, T., Zennaro, R. G., Lonardo, A., & Loria, P. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0149 · Cited by 27
Kocabay, G., Karabay, C. Y., Çolak, Y., Oduncu, V., Kalaycı, A., Akgün, T., Güler, A., & Kırma, C. (2013) · Clinical Science · doi:10.1042/cs20130298 · Cited by 27
Barbato, A., Iacone, R., Tarantino, G., Russo, O., Sorrentino, P., Avallone, S., Galletti, F., Farinaro, E., Valle, E. D., & Strazzullo, P. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0240-9 · Cited by 27
Cited by
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239
PPAR control of metabolism and cardiovascular functions
Montaigne, D., Butruille, L., & Staels, B. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00569-6 · Cited by 942
Eslam, M., Sarin, S. K., Wong, V. W.-S., Fan, J.-G., Kawaguchi, T., Ahn, S. H., Zheng, M.-H., Shiha, G., Yilmaz, Y., Gani, R., et al. (2020) · Hepatology International · doi:10.1007/s12072-020-10094-2 · Cited by 833
A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH
Francque, S. M., Bedossa, P., Ratziu, V., Anstee, Q. M., Bugianesi, E., Sanyal, A. J., Loomba, R., Harrison, S. A., Balabanska, R., Mateva, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2036205 · Cited by 801
Self-citationChanging epidemiology, global trends and implications for outcomes of NAFLD
Wong, V. W.-S., Ekstedt, M., Wong, G. L.-H., & Hagström, H. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.04.036 · Cited by 765
Metadata
- Authors
- Francque, S. M., van der Graaff, D., & Kwanten, W. J.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 65
- Issue
- 2
- Pages
- 425-443
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2341568598
- Cited by
- 556
- References
- 216
- FWCI
- 34.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.